Targeting microbial biofilms: current and prospective therapeutic strategies

H Koo, RN Allan, RP Howlin, P Stoodley… - Nature Reviews …, 2017 - nature.com
Biofilm formation is a key virulence factor for a wide range of microorganisms that cause
chronic infections. The multifactorial nature of biofilm development and drug tolerance …

New approaches to the treatment of biofilm-related infections

M Wilkins, L Hall-Stoodley, RN Allan, SN Faust - Journal of Infection, 2014 - Elsevier
Bacteria causing chronic infections predominately grow as surface-attached, sessile
communities known as biofilms. Biofilm-related infections including cystic fibrosis lung …

[HTML][HTML] Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis

RP Howlin, K Cathie, L Hall-Stoodley, V Cornelius… - Molecular Therapy, 2017 - cell.com
Despite aggressive antibiotic therapy, bronchopulmonary colonization by Pseudomonas
aeruginosa causes persistent morbidity and mortality in cystic fibrosis (CF). Chronic P …

Reactive oxygen: a novel antimicrobial mechanism for targeting biofilm-associated infection

MS Dryden, J Cooke, RJ Salib, RE Holding… - Journal of global …, 2017 - Elsevier
Reactive oxygen species (ROS) is a novel therapeutic strategy for topical or local application
to wounds, mucosa or internal structures where there may be heavy bacterial bioburden with …

[HTML][HTML] Pronounced Metabolic Changes in Adaptation to Biofilm Growth by Streptococcus pneumoniae

RN Allan, P Skipp, J Jefferies, SC Clarke, SN Faust… - PLoS …, 2014 - journals.plos.org
Streptococcus pneumoniae accounts for a significant global burden of morbidity and
mortality and biofilm development is increasingly recognised as important for colonization …

Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis

A Edwards, Y Gao, RN Allan, D Ball, H De Graaf… - Thorax, 2017 - thorax.bmj.com
The impact of immunosuppression on interferon-γ release assays and novel cytokine
biomarkers of TB infection, mycobacteria-specific IL-2, IP-10 and TNF-α responses was …

[HTML][HTML] An integrated model system to gain mechanistic insights into biofilm-associated antimicrobial resistance in Pseudomonas aeruginosa MPAO1

AR Varadarajan, RN Allan, JDP Valentin… - npj Biofilms and …, 2020 - nature.com
Pseudomonas aeruginosa MPAO1 is the parental strain of the widely utilized transposon
mutant collection for this important clinical pathogen. Here, we validate a model system to …

Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa

O Soren, A Rineh, DG Silva, Y Cai… - Journal of …, 2020 - academic.oup.com
Objectives The cephalosporin nitric oxide (NO)-donor prodrug DEA-C3D ('DiEthylAmin-
Cephalosporin-3′-Diazeniumdiolate') has been shown to initiate the dispersal of biofilms …

Multi-excitation Raman spectroscopy for label-free, strain-level characterization of bacterial pathogens in artificial sputum media

AP Lister, CJ Highmore, N Hanrahan, J Read… - Analytical …, 2022 - ACS Publications
The current methods for diagnosis of acute and chronic infections are complex and skill-
intensive. For complex clinical biofilm infections, it can take days from collecting and …

Staphylococcus aureus internalization in mast cells in nasal polyps: Characterization of interactions and potential mechanisms

SM Hayes, TC Biggs, SP Goldie, PG Harries… - Journal of Allergy and …, 2020 - Elsevier
Background Chronic rhinosinusitis (CRS) with nasal polyps is a common chronic condition.
The exact cause of nasal polyps remains unknown. Recently, we made the novel …